Jiangsu Alphamab, 3D Medicines and Glenmark sign license pact for KN035 (Envafolimab) EP News Bureau Jan 25, 2024 Glenmark will be responsible for further developing, registering, and commercialising Envafolimab in India, Asia Pacific, Middle…
